Market Overview:
The global oral solid dosage forms (OSDF) and pharma excipients market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for OSDF from various end-use industries, such as industrial and non-industrial applications. In terms of type, glycerin is expected to hold a dominant position in the global oral solid dosage forms (OSDF) and pharma excipients market during the forecast period. This can be attributed to its properties such as high purity, low toxicity, and non-irritating nature. In terms of application, industrial application is projected to account for a major share in the global oral solid dosage forms (OSDF) and pharma excipients market during the forecast period.
 and Pharma Excipients Industry Outlook.svg)
Product Definition:
Oral solid dosage forms (OSDF) are tablets, capsules, and powders that are taken by mouth. They can be used to treat a variety of conditions, including infections, heart disease, and cancer. Oral solid dosage forms are important because they allow patients to take medications in a convenient and controlled manner. The doses can be tailored to meet the needs of each individual patient. Additionally, oral solid dosage forms can be combined with other ingredients to improve their effectiveness or palatability.
Glycerin:
Glycerin is a natural by-product of fat and oil. It is found in animal fats, vegetable oils, and pharmaceutical drugs. It has the ability to dissolve in water as well as form a gel-like substance when mixed with alcohol or other liquids.
Propylene Glycol:
Propylene glycol is a colorless, odorless liquid that is miscible in water and alcohol. It has a slight sweet taste. It is commercially available as an FDA approved drug (E-ZPass) under the name “Allyl diglycol” or “2-Ethylhexanol”.
Application Insights:
The non-industrial application segment led the global market in 2017 and is expected to witness significant growth over the forecast period. Non-industrial applications of oral solid dosage forms (excluding drugs for babies & children) include diabetes, cardiovascular diseases, respiratory problems, gastrointestinal disorders and others.
Diabetes was one of the major segments that accounted for a substantial share in 2017 owing to increasing incidences of diabetes worldwide. According to WHO¢â‚¬â„¢s latest statistics published in 2018 regarding diabetes prevalence globally; it has been estimated that about 642 million people were affected by this disease across all age groups globally. Prevalence rates for type 2 diabetes are highest among adults aged between 30 to 44 years while those above 65 years have higher prevalence rates of type 1 diabetes.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to increasing product demand for oral dosage forms, growing pharmaceutical industry, and favorable regulations & policies by governments of various countries such as China, India, South Korea & Japan. These factors are also expected to drive the regional market during the forecast period.
The Asia Pacific is anticipated to witness significant growth in terms of revenue generation from 2018 to 2030 owing mainlyto rising geriatric population coupled with high unmet medical needs resulting into increased disease prevalence rates which will boost drug sales across this region. Moreover, economic development along with rapid urbanization has led many countries such as India & China where people are moving towards a modern lifestyle leading into higher spending on healthcare products including solid dosage forms (OSDF). This factor will further fuel regional growth during the projected time frame.
Europe was estimated at USD X million in 2017.
Growth Factors:
- Increasing demand for oral solid dosage forms from the developing countries owing to the increase in population and rising incidence of chronic diseases.
- Rising demand for pharma excipients due to their increasing use in various dosage forms such as tablets, capsules, ointments, etc., which is attributed to their properties such as solubility, stability, and compatibility with other ingredients.
- Technological advancements in the field of oral solid dosage form manufacturing that has led to the development of novel drug delivery systems (NDDS) such as extended-release tablets and orally disintegrating tablets (ODTs).
- Growing focus on research and development activities by pharmaceutical companies for new drug discovery that would lead to an increase in demand for pharma excipients used during formulation development stage itself thereby reducing time-to-market for new drugs/products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Research Report
By Type
Glycerin, Propylene Glycol, Sorbitol, Mannitol, Others
By Application
Industrial Application, Non-industrial Application
By Companies
ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, DowDuPont, Evonik, J.M. Huber Corporation, Cargill, Eastman Chemical Company, ABITEC Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report Segments:
The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented on the basis of:
Types
Glycerin, Propylene Glycol, Sorbitol, Mannitol, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Industrial Application, Non-industrial Application
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ABITEC Corporation
- AkzoNobel
- Archer Daniels Midland (ADM)
- BASF
- DowDuPont
- Evonik
- J.M. Huber Corporation
- Cargill
- Eastman Chemical Company
- ABITEC Corporation
 and Pharma Excipients Market Overview.svg)
Highlights of The Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glycerin
- Propylene Glycol
- Sorbitol
- Mannitol
- Others
- By Application:
- Industrial Application
- Non-industrial Application
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 and Pharma Excipients Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OSDF is a term used to describe oral solid dosage forms. It includes both pharmaceutical excipients and inert ingredients. Pharmaceutical excipients are substances that are added to medications in order to make them more effective, safe, or stable. Inert ingredients are those that do not have any therapeutic properties and serve only as carriers or diluents for the active ingredients.
Some of the key players operating in the oral solid dosage forms (osdf) and pharma excipients market are ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, DowDuPont, Evonik, J.M. Huber Corporation, Cargill, Eastman Chemical Company, ABITEC Corporation.
The oral solid dosage forms (osdf) and pharma excipients market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size & Forecast, 2020-2028
4.5.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size and Y-o-Y Growth
4.5.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Glycerin
5.2.2 Propylene Glycol
5.2.3 Sorbitol
5.2.4 Mannitol
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Industrial Application
6.2.2 Non-industrial Application
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Glycerin
9.6.2 Propylene Glycol
9.6.3 Sorbitol
9.6.4 Mannitol
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Industrial Application
9.10.2 Non-industrial Application
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Glycerin
10.6.2 Propylene Glycol
10.6.3 Sorbitol
10.6.4 Mannitol
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Industrial Application
10.10.2 Non-industrial Application
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Glycerin
11.6.2 Propylene Glycol
11.6.3 Sorbitol
11.6.4 Mannitol
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Industrial Application
11.10.2 Non-industrial Application
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Glycerin
12.6.2 Propylene Glycol
12.6.3 Sorbitol
12.6.4 Mannitol
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Industrial Application
12.10.2 Non-industrial Application
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Glycerin
13.6.2 Propylene Glycol
13.6.3 Sorbitol
13.6.4 Mannitol
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Industrial Application
13.10.2 Non-industrial Application
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Competitive Dashboard
14.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ABITEC Corporation
14.3.2 AkzoNobel
14.3.3 Archer Daniels Midland (ADM)
14.3.4 BASF
14.3.5 DowDuPont
14.3.6 Evonik
14.3.7 J.M. Huber Corporation
14.3.8 Cargill
14.3.9 Eastman Chemical Company
14.3.10 ABITEC Corporation
